Study reveals high rates of opioid use in NZ pregnancies
Photo:
Unsplash
In unexpected findings New Zealand has one of the highest rates of prescribed opioid use during pregnancy, according to new research.
The data comes from a study led by the University of New South Wales, which tracked prescribed opioid use across 13 countries since the year 2000.
Of the countries - which included Australia, Canada, the US, Denmark and the UK - New Zealand had the third-highest rate.
Almost 8 per cent of pregnancies in New Zealand were exposed to an opioid, compared to only 4 per cent in Canada and 0.4 per cent in the UK.
Co-author of the research is Dr Sarah Donald, of the University of Otago.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RNZ News
2 hours ago
- RNZ News
Approaching life-changing diagnosis for "missing millions" with ME/CFS
Photo: Professor Warren Tate Photo: Supplied Anyone who has or knows someone with ME, chronic syndrome fatigue or long covid knows that being believed is one of the toughest parts of having the condition. University of Otago Emeritus Professor Warren Tate has dedicated his life to researching ME/CFS and is considered a leading authority on long covid. Along with his team, he has been developing a diagnostic test, that so far has shown promising results. If implemented, it would be life-changing. Warren and his co-researcher Dr Katie Peppercorn have also released a one-of-a-kind book to help clinicians and researchers find ways of better understanding post-viral conditions and improve the lives of those 'missing millions' affected with ME/CFS and most recently long covid.
RNZ News
2 hours ago
- RNZ News
Approaching life-changing diagnosis for 'missing millions'
Photo: Professor Warren Tate Photo: Supplied Anyone who has or knows someone with ME, chronic syndrome fatigue or long covid knows that being believed is one of the toughest parts of having the condition. University of Otago Emeritus Professor Warren Tate has dedicated his life to researching ME/CFS and is considered a leading authority on long covid. Along with his team, he has been developing a diagnostic test, that so far has shown promising results. If implemented, it would be life-changing. Warren and his co-researcher Dr Katie Peppercorn have also released a one-of-a-kind book to help clinicians and researchers find ways of better understanding post-viral conditions and improve the lives of those 'missing millions' affected with ME/CFS and most recently long covid.
Otago Daily Times
9 hours ago
- Otago Daily Times
Bid to help families results in discovery
Louise Bicknell. PHOTO: SUPPLIED A journey to help 10 New Zealand families get answers for rare brain disorders affecting their children has led to the discovery of the genetic cause. Co-author and associate professor at the University of Otago Rare Disorder Genetics Laboratory Louise Bicknell said the discovery shed new light on the "incredibly complex" process by which human bodies created the "instruction manuals" essential for building and maintaining our brains. "Our bodies rely on a precise process called 'splicing', to read and process genetic instructions from our DNA and help generate the building blocks required in our body. "While it's known that problems with the machinery that co-ordinates splicing can cause various genetic disorders, this new finding adds to a small but growing recognition of the potential severe impact on brain development in particular." The research team studied 10 New Zealand families impacted by a severe genetic disorder that resulted in affected individuals having profound pre- and postnatal microcephaly (smaller head circumference), with pontocerebellar hypoplasia (underdevelopment in brain stem and cerebellum), seizures and severe intellectual disability. The findings, published in the American Journal of Human Genetics, pinpointed specific changes in a gene called CRNKL1. "Our journey to this discovery began here in New Zealand, through trying to help New Zealand families get answers for genetic disorders affecting their children," Prof Bicknell said. "Then, using our international connections, we were able to identify other families around the world, which was crucial for confirming our findings and understanding the full impact of these genetic changes." In a striking discovery, nine of these families showed genetic changes in the exact same spot in the CRNKL1 gene, she said. All the affected children shared the same severe features, highlighting the strong link between these specific genetic changes and the disorder. Lead author and postdoctoral fellow at the University of Otago Rare Disorder Genetics Laboratory Dr Sankalita Ray Das said the research showed CRNKL1 was crucial for healthy brain development, and that specific parts of the splicing machine had highly specialised roles — far more intricate than scientists previously thought. She said the finding also offered further clues into the complex ways human genes guided brain development.
